BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood. 2002;100:2637-2641. [PMID: 12239179 DOI: 10.1182/blood-2002-03-0798] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007;20:426-439, table of contents. [PMID: 17630333 DOI: 10.1128/cmr.00009-07] [Cited by in Crossref: 86] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
2 Said ZN, Sayed MH, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, Mouftah F, Azzab MB, Goubran H, Bassili A. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol. 2013;5:64-73. [PMID: 23646231 DOI: 10.4254/wjh.v5.i2.64] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
3 Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Transfusion 2006;46:2047-52. [PMID: 17176315 DOI: 10.1111/j.1537-2995.2006.01031.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
4 Kuhns MC, Kleinman SH, Mcnamara AL, Rawal B, Glynn S, Busch MP. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy: HBsAg AND HBV DNA LEVELS IN HbsAg-POSITIVE, ANTI-HBc-REACTIVE BLOOD DONORS. Transfusion 2004;44:1332-9. [DOI: 10.1111/j.1537-2995.2004.04055.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
5 Kiely P, Walker K, Parker S, Cheng A. Analysis of sample-to-cutoff ratios on chemiluminescent immunoassays used for blood donor screening highlights the need for serologic confirmatory testing. Transfusion 2010;50:1344-51. [PMID: 20113456 DOI: 10.1111/j.1537-2995.2009.02572.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
6 Xirong L, Rui L, Xiaoli Y, Qiuyan H, Bikui T, Sibo Z, Naishuo Z. Hepatitis B virus can be inhibited by DNA methyltransferase 3a via specific zinc-finger-induced methylation of the X promoter. Biochemistry (Mosc). 2014;79:111-123. [PMID: 24794726 DOI: 10.1134/s0006297914020047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
7 Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Hepatitis B core antibody testing in Indian blood donors: A double-edged sword! Asian J Transfus Sci. 2012;6:10-13. [PMID: 22623835 DOI: 10.4103/0973-6247.95043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
8 Scheiblauer H, Heiden M, Funk M, Oberle D, Kreß J, Jork C, Chudy M. Detection of hepatitis B virus infection in German blood donors 2008-2015. Vox Sang 2020;115:152-61. [PMID: 32023664 DOI: 10.1111/vox.12890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. J Infect 2005;51:24-9. [PMID: 15979486 DOI: 10.1016/j.jinf.2004.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
10 Allain J. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening. Vox Sang 2007;92:254-7. [DOI: 10.1111/j.1423-0410.2006.00874.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
11 Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J 2011;8:513. [PMID: 22074048 DOI: 10.1186/1743-422X-8-513] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
12 Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujimie H, Tsutsumi T, Kimura S, Koike K, Norjiri N, Juji T, Hoshino H, Hino K. HBV DNA in serum of HBsAg‐negative, anti‐HBc‐positive blood donors. Transfusion 2002;42:1616-7. [DOI: 10.1046/j.1537-2995.2002.00298_3.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Zeiler T, Karger R, Slonka J, Ketschmer V, Radsak K. Introduction of anti-HBc testing of blood donors in Germany. Transfus Med 2006;16:441-3. [DOI: 10.1111/j.1365-3148.2006.00685.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Romanò L, Velati C, Cambiè G, Fomiatti L, Galli C, Zanetti AR; SIMTI study group for HBV infection among first-time blood donors. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood Transfus. 2013;11:281-288. [PMID: 23399361 DOI: 10.2450/2012.0160-12] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
15 García-Montalvo BM, Farfán-Ale JA, Acosta-Viana KY, Puerto-Manzano FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med. 2005;15:371-378. [PMID: 16202051 DOI: 10.1111/j.1365-3148.2005.00610.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
16 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J 2016;13:76. [PMID: 27150469 DOI: 10.1186/s12985-016-0533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005;45:133-40. [PMID: 15660820 DOI: 10.1111/j.1537-2995.2004.04279.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 6.0] [Reference Citation Analysis]
18 Shastry S, Bhat SS. Prevention of post-transfusion hepatitis by screening of antibody to hepatitis B core antigen in healthy blood donors. Mediterr J Hematol Infect Dis 2011;3:e2011062. [PMID: 22220259 DOI: 10.4084/MJHID.2011.062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
19 Stolz M, Tinguely C, Graziani M, Fontana S, Gowland P, Buser A, Michel M, Canellini G, Züger M, Schumacher P, Lelie N, Niederhauser C. Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region. Transfusion 2010;50:2695-706. [PMID: 20573074 DOI: 10.1111/j.1537-2995.2010.02732.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
20 Findik D, Arslan U, Baykan M. Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen. Eur J Intern Med. 2007;18:571-575. [PMID: 18054706 DOI: 10.1016/j.ejim.2007.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
21 Velati C, Fomiatti L, Baruffi L, Piccinini V, Prati D, Reina A, Lobbiani A, Zanetti A, Romanò L. Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group. Blood Transfus 2011;9:455-61. [PMID: 21839007 DOI: 10.2450/2011.0014-11] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
22 Hennig H, Osterrieder N, Müller-Steinhardt M, Teichert HM, Kirchner H, Wandinger KP. Detection of Marek's disease virus DNA in chicken but not in human plasma. J Clin Microbiol 2003;41:2428-32. [PMID: 12791859 DOI: 10.1128/JCM.41.6.2428-2432.2003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
23 Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J 2011;8:96. [PMID: 21375724 DOI: 10.1186/1743-422X-8-96] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
24 Mazet-Wagner AA, Baclet MC, Loustaud-Ratti V, Denis F, Alain S. Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients. J Virol Methods 2006;138:70-9. [PMID: 16962180 DOI: 10.1016/j.jviromet.2006.07.019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
25 Allain JP. Epidemiology of Hepatitis B virus and genotype. J Clin Virol. 2006;36 Suppl 1:S12-S17. [PMID: 16831687 DOI: 10.1016/s1386-6532(06)80003-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
26 Larrubia JR. Occult hepatitis B virus infection: a complex entity with relevant clinical implications. World J Gastroenterol. 2011;17:1529-1530. [PMID: 21472115 DOI: 10.3748/wjg.v17.i12] [Reference Citation Analysis]
27 Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, Chalermpolprapa V, Nanta S, Puarattana-Aroonkorn N, Tonmat S. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis. 2013;56:1704-1712. [PMID: 23487379 DOI: 10.1093/cid/cit166] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
28 Alshayea AI, Eid GE, El-Hazmi MM, Alhetheel AF. Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Med J 2016;37:1114-9. [PMID: 27652363 DOI: 10.15537/smj.2016.10.14708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
30 Kidd-Ljunggren K, Holmberg A, Bläckberg J, Lindqvist B. High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect. 2006;64:352-357. [PMID: 17046105 DOI: 10.1016/j.jhin.2006.06.029] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
31 De Paschale M, Manco MT, Belvisi L, Brando B, Latella S, Agrappi C, Mirri P, Gatti A, Clerici P. Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects. Blood Transfus 2012;10:344-50. [PMID: 22682333 DOI: 10.2450/2012.0085-11] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
32 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-1125/1/142] [Reference Citation Analysis]
33 Schmidt M, Jimenez A, Mühlbacher A, Oota S, Blanco L, Sakuldamrongpanich T, Schennach H, Seifried E. Head-to-head comparison between two screening systems for HBsAG, anti-HBc, anti-HCV and HIV combination immunoassays in an international, multicentre evaluation study. Vox Sang 2015;109:114-21. [PMID: 25899479 DOI: 10.1111/vox.12259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Kiruthika S, Bhat R, Dash R, Rathore AS, Vivekanandan P, Jayaram B. A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus. Sci Rep 2021;11:11723. [PMID: 34083665 DOI: 10.1038/s41598-021-91196-1] [Reference Citation Analysis]
35 van de Laar TJ, Marijt-van der Kreek T, Molenaar-de Backer MW, Hogema BM, Zaaijer HL. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country. Transfusion 2015;55:1206-13. [PMID: 25494685 DOI: 10.1111/trf.12962] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
36 Motta-castro ARC, Martins RMB, Araujo NM, Niel C, Facholi GB, Lago BV, Mello FCA, Gomes SA. Molecular epidemiology of hepatitis B virus in an isolated Afro-Brazilian community. Arch Virol 2008;153:2197-205. [DOI: 10.1007/s00705-008-0237-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
37 Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2010;14:e308-10. [PMID: 19656713 DOI: 10.1016/j.ijid.2009.05.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
38 Khorami F, Sobhani SA, Davoudian P, Khajeh E. Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran. Electron Physician 2013;5:659-63. [PMID: 26120400 DOI: 10.14661/2013.659-663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Sun HY, Lee HC, Liu CE, Yang CL, Su SC, Ko WC, Lin CY, Tsai JJ, Wong WW, Ho MW, Cheng SH, Lin YH, Miao WJ, Hung CC. Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunity. J Viral Hepat 2010;17:578-87. [PMID: 19818002 DOI: 10.1111/j.1365-2893.2009.01212.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
40 Allain J. Occult hepatitis B virus infection. Transfusion Clinique et Biologique 2004;11:18-25. [DOI: 10.1016/j.tracli.2003.11.007] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 5.4] [Reference Citation Analysis]
41 Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, Yao JD, Wengenack NL, Rosenblatt JE, Cockerill FR. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006;19:165-256. [PMID: 16418529 DOI: 10.1128/cmr.19.1.165-256.2006] [Cited by in Crossref: 809] [Cited by in F6Publishing: 274] [Article Influence: 53.9] [Reference Citation Analysis]
42 Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis 2016;85:159-67. [PMID: 27009896 DOI: 10.1016/j.diagmicrobio.2015.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
43 Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, Stone VE, Kaplan JE. Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases 2004;39:609-29. [DOI: 10.1086/423390] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 6.7] [Reference Citation Analysis]
44 Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
45 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-11] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 10.1] [Reference Citation Analysis]
46 María García-montalvo B, Patricia Ventura-zapata L. Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico. Annals of Hepatology 2011;10:133-41. [DOI: 10.1016/s1665-2681(19)31561-3] [Cited by in Crossref: 14] [Article Influence: 1.4] [Reference Citation Analysis]
47 Kandpal M, Samal J, Biswas B, Negi A, Mishra VC, Tyagi N, Raina V, Vivekanandan P. Enhanced hepatitis B virus (HBV) pre-genomic RNA levels and higher transcription efficiency of defective HBV genomes. J Gen Virol 2015;96:3109-17. [PMID: 26242411 DOI: 10.1099/jgv.0.000256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
48 Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP; Retrovirus Epidemiology Donor Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion. 2003;43:696-704. [PMID: 12757519 DOI: 10.1046/j.1537-2995.2003.00391.x] [Cited by in Crossref: 131] [Cited by in F6Publishing: 130] [Article Influence: 7.3] [Reference Citation Analysis]
49 Knöll A, Hartmann A, Hamoshi H, Weislmaier K, Jilg W. Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. World J Gastroenterol 2006;12:1255-60. [PMID: 16534880 DOI: 10.3748/wjg.v12.i8.1255] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
50 Juhl D, Luhm J, Görg S, Ziemann M, Hennig H. Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen: ANTI-HBc TESTING OF BLOOD DONORS. Transfusion 2011;51:1477-85. [DOI: 10.1111/j.1537-2995.2010.03031.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
51 Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51:798-809. [PMID: 19615780 DOI: 10.1016/j.jhep.2009.05.020] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 9.6] [Reference Citation Analysis]
52 Hwang SH, Oh HB, Choi SE, Kim HH, Chang CL, Lee EY, Son HC. [Meta-analysis for the pooled sensitivity and specificity of hepatitis B surface antigen rapid tests]. Korean J Lab Med 2008;28:160-8. [PMID: 18458514 DOI: 10.3343/kjlm.2008.28.2.160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
53 Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011;17:1927-1938. [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 83] [Article Influence: 9.6] [Reference Citation Analysis]
54 Mawhorter SD, Avery RK. Can Donors With Prior Hepatitis Be Safely Used for Heart Transplantation? The Journal of Heart and Lung Transplantation 2006;25:805-13. [DOI: 10.1016/j.healun.2006.03.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
55 Liu C, Chen D, Chen P. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 2006;36:S33-44. [DOI: 10.1016/s1386-6532(06)80007-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
56 Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007;47:1794-802. [PMID: 17880603 DOI: 10.1111/j.1537-2995.2007.01394.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
57 Mok CC. Hepatitis B and C infection in patients undergoing biologic and targeted therapies for rheumatic diseases. Best Pract Res Clin Rheumatol 2018;32:767-80. [PMID: 31427054 DOI: 10.1016/j.berh.2019.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
58 Mori S, Fujiyama S. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations. World J Gastroenterol 2015;21:10274-89. [PMID: 26420955 DOI: 10.3748/wjg.v21.i36.10274] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 46] [Article Influence: 11.2] [Reference Citation Analysis]
59 Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors. Virol J 2016;13:36. [PMID: 26944046 DOI: 10.1186/s12985-016-0492-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
60 Ingman M, Lindqvist B, Kidd-ljunggren K. Novel mutation in Hepatitis B virus preventing HBeAg production and resembling primate strains. Journal of General Virology 2006;87:307-10. [DOI: 10.1099/vir.0.81562-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Kumar H, Gupta PK, Jaiprakash M. The Role of anti-HBc IgM in Screening of Blood Donors. Med J Armed Forces India 2007;63:350-2. [PMID: 27408047 DOI: 10.1016/S0377-1237(07)80013-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
62 Kaminski G, Alnaqdy A, Al-belushi I, Nograles J, Al-dhahry SH. Evidence of Occult Hepatitis B Virus Infection among Omani Blood Donors: A Preliminary Study. Med Princ Pract 2006;15:368-72. [DOI: 10.1159/000094271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
63 Fortes HM, Ribeiro LC, Perazolo GF, Souto FJD. Hepatitis B virus screening in contacts of blood donors with antibodies against core protein (anti-HBc), but without surface antigen (HBsAg). Mem Inst Oswaldo Cruz 2006;101:195-9. [DOI: 10.1590/s0074-02762006000200011] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
64 Satoh K, Iwata-Takakura A, Yoshikawa A, Gotanda Y, Tanaka T, Yamaguchi T, Mizoguchi H. A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection. Vox Sang. 2008;95:174-180. [PMID: 19121181 DOI: 10.1111/j.1423-0410.2008.01091.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
65 Konnick EQ, Erali M, Ashwood ER, Hillyard DR. Evaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNA. J Clin Microbiol. 2005;43:596-603. [PMID: 15695651 DOI: 10.1128/jcm.43.2.596-603.2005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008;48:1001-1026. [PMID: 18454738 DOI: 10.1111/j.1537-2995.2008.01701.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
67 Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion. 2005;45:1247-1257. [PMID: 16078909 DOI: 10.1111/j.1537-2995.2005.00198.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
68 Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Houspie L, Verbeeck J, Rahman M, Maes P, Vanwijngaerden E, Nevens F, Van Ranst M. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection. J Med Virol. 2011;83:1876-1884. [PMID: 21915860 DOI: 10.1002/jmv.22174] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
69 Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology. 2006;44:1666-1674. [PMID: 17133474 DOI: 10.1002/hep.21413] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 5.7] [Reference Citation Analysis]
70 Al-Rubaye A, Tariq Z, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol 2016;3:e000067. [PMID: 26966550 DOI: 10.1136/bmjgast-2015-000067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004;86:83-91. [PMID: 15023176 DOI: 10.1111/j.0042-9007.2004.00406.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 183] [Article Influence: 11.3] [Reference Citation Analysis]
72 Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Blood Transfus 2017;15:6-12. [PMID: 27416568 DOI: 10.2450/2016.0268-15] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
73 Juhl D, Knobloch JK, Görg S, Hennig H. Comparison of Two Test Strategies for Clarification of Reactive Results for Anti-HBc in Blood Donors. Transfus Med Hemother 2016;43:37-43. [PMID: 27022321 DOI: 10.1159/000441676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
74 . Estimation of HBV transfusion risk. Transfusion 2009;49:1019-21. [DOI: 10.1111/j.1537-2995.2009.02122.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
75 Vital Durand D, Lega J, Fassier T, Zenone T, Durieu I. Élévation modérée, persistante et inexpliquée des transaminases. La Revue de Médecine Interne 2013;34:472-8. [DOI: 10.1016/j.revmed.2013.02.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
76 El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, Abdel-Sattar RM, Ahmady AM, El-Nakeeb A. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008;18:55-61. [PMID: 18279193 DOI: 10.1111/j.1365-3148.2007.00806.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
77 Zeiler T, Karger R, Slonka J, Radsak K, Kretschmer V. Introducing Anti-HBc Screening in Germany – Possible Implications for the Blood Donation Service. Transfus Med Hemother 2006;33:453-8. [DOI: 10.1159/000094784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
78 Al Shaer L, AbdulRahman M, John TJ, AlHashimi A. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Transfusion. 2012;52:2300-2309. [PMID: 22691239 DOI: 10.1111/j.1537-2995.2012.03740.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
79 Gutiérrez-García ML, Fernandez-Rodriguez CM, Lledo-Navarro JL, Buhigas-Garcia I. Prevalence of occult hepatitis B virus infection. World J Gastroenterol. 2011;17:1538-1542. [PMID: 21472117 DOI: 10.3748/wjg.v17.i12.1538] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
80 Masarone M, De Renzo A, La Mura V, Sasso FC, Romano M, Signoriello G, Rosato V, Perna F, Pane F, Persico M. Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma. BMC Gastroenterol 2014;14:31. [PMID: 24533834 DOI: 10.1186/1471-230X-14-31] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]